Dipyridamole

BreastfeedingPediatric
  • TRADE NAMES: Aggrenox (Boehringer Ingelheim); Cardoxin; Cleridium; Coronarine; Coroxin; Curantyl N; Dipridacot; Lodimol; Novo-Dipiradol; Persantin; Persantine (Boehringer Ingelheim)
  • INDICATIONS: Thromboembolic complications following cardiac valve replacement
  • CLASS: Adenosine reuptake inhibitor, Antiplatelet
  • HALF-LIFE: 10–12 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Adenosine, Ceftobiprole, Clopidogrel, Enoxaparin, Fondaparinux, Regadenoson, Reteplase, Riociguat, Tinzaparin

PREGNANCY CATEGORY: B

NOTE

Aggrenox is dipyridamole and aspirin.

Our database has 42 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTHER.


Page last updated 01/17/2022

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top